(Q303646)

hydromorphone (English)

17 November 2016

chemical formula

C₁₇H₁₉NO₃

1 reference

hydromorphone (English)

17 November 2016

canonical SMILES

CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(=O)CC4

1 reference

hydromorphone (English)

17 November 2016

isomeric SMILES

CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3C(=O)CC4

1 reference

hydromorphone (English)

17 November 2016

defined daily dose

20 milligram

oral administration

1 reference

https://www.whocc.no/atc_ddd_index/?code=N02AA03

4 milligram

parenteral route of administration

1 reference

https://www.whocc.no/atc_ddd_index/?code=N02AA03

4 milligram

rectal route of administration

1 reference

https://www.whocc.no/atc_ddd_index/?code=N02AA03

1 reference

14 February 2018

1 reference

14 February 2018

World Health Organisation international non-proprietary name

hydromorphone (English)

1 reference

hydromorphone (English)

medical condition treated

3 October 2016

1 reference

13 December 2016

1 reference

Drug Indications Extracted from FAERS

13 December 2016

1 reference

significant drug interaction

2 October 2018

pethidine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pethidine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(R,R)-tramadol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(R,R)-tramadol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

buprenorphine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

buprenorphine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tapentadol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tapentadol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sufentanil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sufentanil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-methadone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-methadone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

morphine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

morphine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

oxycodone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

oxycodone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fentanyl

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fentanyl

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dihydrocodeine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dihydrocodeine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

codeine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

codeine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

remifentanil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

remifentanil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

alfentanil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

alfentanil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

periciazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(±)-promethazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(±)-promethazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(±)-promethazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pimozide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pimozide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pimozide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fluphenazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fluphenazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fluphenazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-hydroxyzine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-hydroxyzine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-hydroxyzine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

olanzapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

olanzapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

olanzapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

chlorpromazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

chlorpromazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

chlorpromazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

chlorpheniramine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

levomepromazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

levomepromazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

trimeprazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

trimeprazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

nitrazepam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

nitrazepam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

zopiclone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

zopiclone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clobazam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clobazam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dexmedetomidine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dexmedetomidine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-sulpiride

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-sulpiride

1 reference

A reference set of clinically relevant adverse drug-drug interactions

perampanel

1 reference

A reference set of clinically relevant adverse drug-drug interactions

perampanel

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(±)-thiopental

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(±)-thiopental

1 reference

A reference set of clinically relevant adverse drug-drug interactions

midazolam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

midazolam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-baclofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-baclofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

diazepam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

diazepam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

oxazepam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

oxazepam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

phenobarbital

1 reference

A reference set of clinically relevant adverse drug-drug interactions

phenobarbital

1 reference

A reference set of clinically relevant adverse drug-drug interactions

droperidol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

droperidol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

zolpidem

1 reference

A reference set of clinically relevant adverse drug-drug interactions

zolpidem

1 reference

A reference set of clinically relevant adverse drug-drug interactions

primidone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

primidone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

flurazepam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

flurazepam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aripiprazole

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aripiprazole

1 reference

A reference set of clinically relevant adverse drug-drug interactions

haloperidol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

haloperidol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

quetiapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

quetiapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sodium oxybate

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sodium oxybate

1 reference

A reference set of clinically relevant adverse drug-drug interactions

alprazolam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

alprazolam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

lorazepam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

lorazepam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clonazepam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clonazepam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clozapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clozapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

chlordiazepoxide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

chlordiazepoxide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

cognitive disorder

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hypotension

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sedation

1 reference

A reference set of clinically relevant adverse drug-drug interactions

syncope

1 reference

A reference set of clinically relevant adverse drug-drug interactions

physically interacts with

Opioid receptor delta 1

subject has role

agonist

1 reference

17 August 2016

opioid receptor kappa 1

subject has role

agonist

1 reference

17 August 2016

1 reference

Australian pregnancy category C

17 August 2016

pregnancy category

1 reference

imported from Wikimedia project

English Wikipedia

US pregnancy category C

1 reference

imported from Wikimedia project

0 references

opioid receptor agonist

1 reference

5 March 2018

1 reference

Medical Subject Headings

15 March 2018

1 reference

Medical Subject Headings

15 March 2018

HYDROmorphone

Food and Drug Administration

subject named as

Hydromorphone

1 reference

https://www.fda.gov/drugs/medication-errors-related-cder-regulated-drug-products/fda-name-differentiation-project

2 September 2022

0 references

0 references

Hydromorphone

0 references

Identifiers

InChI

InChI=1S/C17H19NO3/c1-18-7-6-17-10-3-5-13(20)16(17)21-15-12(19)4-2-9(14(15)17)8-11(10)18/h2,4,10-11,16,19H,3,5-8H2,1H3/t10-,11+,16-,17-/m0/s1

1 reference

hydromorphone (English)

WVLOADHCBXTIJK-YNHQPCIGSA-N

17 November 2016

InChIKey

2 references

hydromorphone (English)

17 November 2016

ChEBI release 2020-09-01

CAS Registry Number

466-99-9

2 references

hydromorphone (English)

WVLOADHCBXTIJK-YNHQPCIGSA-N

17 November 2016

InChIKey

9 April 2021

https://commonchemistry.cas.org/detail?cas_rn=466-99-9

1 reference

hydromorphone (English)

17 November 2016

1 reference

hydromorphone (English)

17 November 2016

Reaxys registry number

42553

1 reference

hydromorphone (English)

3 October 2016

ChEBI ID

5790

mapping relation type

1 reference

HYDROMORPHONE (English)

17 November 2016

1 reference

splash10-002r-6960000000-9f3d9b17d56e032d76c5

HYDROMORPHONE (English)

17 November 2016

1 reference

inferred from InChIKey

1 reference

0 references

HSDB ID

3341

1 reference

Hazardous Substances Data Bank

28 October 2019

HYDROMORPHONE (English)

10 May 2021

1 reference

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

DSSTOX compound identifier

0 references

0 references

207-383-5

1 reference

hydromorphone (English)

ECHA Substance Infocard ID

17 November 2016

100.006.713

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

100.006.713

27 December 2018

Hydromorphone (English)

quotation

CAS no.: 466-99-9 (English)

1 reference

Hydromorphone (English)

publication date

17 November 2015

1 reference

hydromorphone (English)

17 November 2016

Hydromorphone

0 references

MeSH concept ID

M0006409

0 references

MeSH tree code

D03.132.577.249.562.450

0 references

D03.605.497.607.500

0 references

D03.633.400.686.607.500

0 references

D04.615.723.795.576.450

0 references

RxNorm ID

3423

1 reference

hydromorphone (English)

17 November 2016

1 reference

Hydromorphone (English)

Human Metabolome Database ID

17 November 2016

HMDB0014472

1 reference

based on heuristic

inferred from InChIKey

1 reference

hydromorphone (English)

MedlinePlus drug identifier

17 November 2016

a682013

oral administration

0 references

a601148

injection

0 references

a613035

rectal administration

0 references

NDF-RT ID

N0000147870

1 reference

hydromorphone (English)

17 November 2016

0 references

1 reference

1 reference

hydromorphone (English)

3 October 2016

1 reference

Immune Epitope Database and Analysis Resource

hydromorphone (English)

3 October 2016

1 reference

1 January 2022

0 references

electronic Essential Medicines List medicine ID

0 references

1 reference

28 October 2013

Microsoft Academic ID

0 references

1 reference

26 January 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

1 reference

1 reference

imported from Wikimedia project

German Wikipedia

Store medisinske leksikon ID

hydromorfon

mapping relation type

exact match

subject named as

hydromorfon

1 reference

Store norske leksikon

5 June 2020

1 reference

hydromorphone (English)